The cookie settings on this website are set to 'allow all cookies' to give you the very best experience. Please click Accept Cookies to continue to use the site.

NEW Autoimmune and Cancer Marker Assay: Human CD134 / OX40 ELISA

Aug 22nd 2019

Autoimmune and Cancer Marker Assay: Human CD134 / OX40 ELISAWe are pleased to announce the release of the IBL Human CD134 / OX40 ELISA for serum, EDTA plasma and cell culture supernatant.

CD134/OX40 is a receptor of OX40 ligand (OX40L) transactivated by Tax of HTLV-1. OX40 is expressed in activated CD4+ and CD8+ T cells. OX40 in activated T cells has a role in proliferation of T cells and production of cytokines by binding with OX40L expressed on antigen presenting cells like dendritic cells or activated B cells. In addition, it also can be involved in activated T cell invasion to inflamed areas through binding with OX40L.

Researchers observed that soluble CD134 / OX40 in plasma is significantly higher in acute adult T-cell leukemia subjects compared to HTLV-1 carriers and healthy individuals in recent study. It was also been reported that the HTLV-1 gene in peripheral blood lymphocytes correlated with soluble OX40 levels in plasma of HTLV-1 infected subjects. (See reference below)

Tanaka Y, Takahashi Y, Tanaka R, Miyagi T, Saito M, Fukushima T. Association of high levels of plasma OX40 with acute adult T-cell leukemia. Int J Hematol. 2019 Jan 16.


Product overview:
Catalog Number27110
ControlsNone provided.
Sample TypesSerum, EDTA plasma and cell culture supernatant.
Standards7 standards
Standard Range0 / 15.6 - 1000 pg/mL
Sensitivity6.3 pg/mL
Incubation Time3 hours, 30 min. total incubation time.
FDA StatusResearch Use Only


Click here for package insert.


OUR ASSAY KIT CATEGORIES